Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Marquette, Charles-Hugo"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer.
Autorzy:
Benzaquen J; Department of Pulmonary Medicine and Thoracic Oncology, Nice University Hospital, Pasteur Hospital, FHU OncoAge, Côte d'Azur University, 30, Voie Romaine, 06000, Nice, France. .; CNRS, INSERM, Institute of Research On Cancer and Aging, Côte d'Azur University, Nice, France. .
Bondiau PY; Department of Medical Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Nice, France.
Otto J; Department of Medical Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Nice, France.
Marquette CH; Department of Pulmonary Medicine and Thoracic Oncology, Nice University Hospital, Pasteur Hospital, FHU OncoAge, Côte d'Azur University, 30, Voie Romaine, 06000, Nice, France.; CNRS, INSERM, Institute of Research On Cancer and Aging, Côte d'Azur University, Nice, France.
Berthet JP; Department of Thoracic Surgery, Nice University Hospital, Pasteur Hospital, Nice, France.
Naghavi AO; Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Schiappa R; Department of Medical Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Nice, France.
Hannoun-Levi JM; Department of Medical Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Nice, France.
Padovani B; Department of Radiology, Nice University Hospital, Côte d'Azur University, Nice, France.
Doyen J; CNRS, INSERM, Institute of Research On Cancer and Aging, Côte d'Azur University, Nice, France.; Department of Medical Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Nice, France.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2023 Jun 07; Vol. 18 (1), pp. 97. Date of Electronic Publication: 2023 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/surgery
Radiosurgery*/methods
Humans ; Retrospective Studies ; Treatment Outcome ; Lung
Czasopismo naukowe
Tytuł:
Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.
Autorzy:
Khatir W; Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.
Humbert O; Department of Nuclear Medicine, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
Benzaquen J; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.; Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Bontoux C; Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.
Neels J; Team Metabolic Challenges of Immune Cells in Obesity, Diabetes, and Cardiovascular Disease, Centre Méditerranéen de Médecine Moléculaire (C3M), INSERM, Université Côte d'Azur, Nice, France.
Berland L; Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Rivera FAG; Biobank, Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain.
Allegra M; Biobank Côte d'Azur (BB-0033-00025), Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Salah M; Biobank Côte d'Azur (BB-0033-00025), Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Tanga V; Biobank Côte d'Azur (BB-0033-00025), Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Bordone O; Biobank Côte d'Azur (BB-0033-00025), Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Fayada J; Biobank Côte d'Azur (BB-0033-00025), Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Lespinet-Fabre V; Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Bohly D; Biobank Côte d'Azur (BB-0033-00025), Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Long-Mira E; Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.
Lassalle S; Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.
Vouret V; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.
Brest P; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.
Mograbi B; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.
Maniel C; Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Otto J; Department of Medical Oncology, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
Boutros J; Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Heeke S; Department of Thoracic H&N Medical Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Hofman V; Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.; Biobank Côte d'Azur (BB-0033-00025), Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Marquette CH; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.; Department of Pulmonary Medicine and Thoracic Oncology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Hofman P; Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.; Biobank Côte d'Azur (BB-0033-00025), Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.
Ilié M; Laboratory of Clinical and Experimental Pathology, Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.; Team 4, Institute of Research on Cancer and Aging (IRCAN), CNRS INSERM, Centre Antoine-Lacassagne, Université Côte d'Azur, Nice, France.; Biobank Côte d'Azur (BB-0033-00025), Centre Hospitalier Universitaire de Nice, FHU OncoAge, Université Côte d'Azur, Nice, France.; Department of Thoracic H&N Medical Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2022 Aug; Vol. 12 (8), pp. e1018.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents, Immunological*/pharmacology
Antineoplastic Agents, Immunological*/therapeutic use
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
B7-H1 Antigen/therapeutic use ; Humans ; Immune Checkpoint Inhibitors/therapeutic use
Raport
Tytuł:
Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution.
Autorzy:
Heeke S; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.; Hospital-related Biobank (BB-00033-0025), Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.; FHU OncoAge, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Hofman V; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.; Hospital-related Biobank (BB-00033-0025), Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.; FHU OncoAge, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Ilié M; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.; Hospital-related Biobank (BB-00033-0025), Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.; FHU OncoAge, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Allegra M; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Lespinet V; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Bordone O; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Benzaquen J; FHU OncoAge, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.; Pulmonary Department, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Boutros J; Pulmonary Department, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Poudenx M; FHU OncoAge, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.; Pulmonary Department, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Lalvée S; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Tanga V; Hospital-related Biobank (BB-00033-0025), Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Salacroup C; Hospital-related Biobank (BB-00033-0025), Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Bonnetaud C; Hospital-related Biobank (BB-00033-0025), Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France.
Marquette CH; FHU OncoAge, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France. marquette..; Pulmonary Department, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France. marquette..
Hofman P; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France. .; Hospital-related Biobank (BB-00033-0025), Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France. .; FHU OncoAge, Pasteur Hospital, Université Côte d'Azur, 30 Avenue de la Voie Romaine, 06000, Nice, France. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2020 Feb 17; Vol. 18 (1), pp. 87. Date of Electronic Publication: 2020 Feb 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma*
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
High-Throughput Nucleotide Sequencing ; Humans ; Liquid Biopsy ; Lung ; Prospective Studies
Czasopismo naukowe
Tytuł:
Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small-cell lung cancer: Results of a French prospective multicenter trial (EVIEPEB).
Autorzy:
Chouaid C; Department of Pneumology, CHI Créteil, Créteil, France.
Salaün M; Department of Pneumology, CHU de Rouen, Rouen, France.
Gounant V; Department of Pneumology CHU Bichat, APHP, Paris, France.
Febvre M; Department of Pneumology, CHU Tenon, APHP, Paris, France.
Vergnon JM; Department of Pneumology, CHU Saint-Etienne, Saint-Etienne, France.
Jouniaux V; Department of Pneumology, CHU d'Amiens, Amiens, France.
Fournier C; Department of Pneumology CHU de Lille, Lille, France.
Lachkar S; Department of Pneumology, CHU de Rouen, Rouen, France.
Hermant C; Department of Pneumology, CHU de Toulouse, Toulouse, France.
Raspaud C; Clinique Pasteur Toulouse, Toulouse, France.
Quantin X; Department of Pneumology, CHU Montpellier, Montpellier, France.
Quiot JJ; Department of Pneumology, CHU Brest, Brest, France.
Molard A; Department of Pneumology, CHU Strasbourg, Strasbourg, France.
Dayen C; Department of Pneumology, CH Saint-Quentin, Saint-Quentin, France.
Marquette CH; Department of Pneumology, CHU Nice, Nice, France.
Lena H; Department of Pneumology, CHU de Rennes, Rennes, France.
Zalcman G; Department of Pneumology CHU Bichat, APHP, Paris, France.
Thiberville L; Department of Pneumology, CHU de Rouen, Rouen, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Jan 07; Vol. 14 (1), pp. e0208992. Date of Electronic Publication: 2019 Jan 07 (Print Publication: 2019).
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*diagnosis
Endoscopic Ultrasound-Guided Fine Needle Aspiration/*methods
Lung Neoplasms/*diagnosis
Neoplasm Staging/*methods
Adult ; Aged ; Aged, 80 and over ; Cost-Benefit Analysis ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease.
Autorzy:
Ilie M; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France; Human Biobank BB-0033-00025, Pasteur Hospital, Nice, France; IRCAN Team 3, INSERM U1081/UMR CNRS 7284, Faculty of Medicine of Nice, University of Nice Sophia Antipolis, Nice, France.
Hofman V; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France; Human Biobank BB-0033-00025, Pasteur Hospital, Nice, France; IRCAN Team 3, INSERM U1081/UMR CNRS 7284, Faculty of Medicine of Nice, University of Nice Sophia Antipolis, Nice, France.
Long-Mira E; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France; IRCAN Team 3, INSERM U1081/UMR CNRS 7284, Faculty of Medicine of Nice, University of Nice Sophia Antipolis, Nice, France.
Selva E; Human Biobank BB-0033-00025, Pasteur Hospital, Nice, France.
Vignaud JM; Department of Pathology, Central Hospital, University of Nancy, Nancy, France.
Padovani B; Department of Radiology, Pasteur Hospital, Nice, France.
Mouroux J; Department of Thoracic Surgery, Pasteur Hospital, Nice, France.
Marquette CH; IRCAN Team 3, INSERM U1081/UMR CNRS 7284, Faculty of Medicine of Nice, University of Nice Sophia Antipolis, Nice, France; Department of Pulmonary Medicine, Pasteur Hospital, Nice, France.
Hofman P; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France; Human Biobank BB-0033-00025, Pasteur Hospital, Nice, France; IRCAN Team 3, INSERM U1081/UMR CNRS 7284, Faculty of Medicine of Nice, University of Nice Sophia Antipolis, Nice, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Oct 31; Vol. 9 (10), pp. e111597. Date of Electronic Publication: 2014 Oct 31 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Early Detection of Cancer/*methods
Lung Neoplasms/*diagnosis
Lung Neoplasms/*pathology
Pulmonary Disease, Chronic Obstructive/*complications
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Immunohistochemistry ; Lung Neoplasms/complications ; Male ; Middle Aged ; Neoplastic Cells, Circulating/pathology
Czasopismo naukowe
Tytuł:
Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.
Autorzy:
Sanfiorenzo C; Institute for Research on Cancer and Ageing in Nice IRCAN, INSERM U1081-CNRS UMR 7284, Team 3, Nice, France.
Ilie MI
Belaid A
Barlési F
Mouroux J
Marquette CH
Brest P
Hofman P
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013; Vol. 8 (1), pp. e54596. Date of Electronic Publication: 2013 Jan 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*blood
Lung Neoplasms/*blood
MicroRNAs/*blood
Aged ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł:
Fatal interstitial lung disease associated with oral erlotinib therapy for lung cancer.
Autorzy:
Makris D; Pulmonary and Thoracic Oncology Department, CHRU of Lille, Lille, France. <>
Scherpereel A
Copin MC
Colin G
Brun L
Lafitte JJ
Marquette CH
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2007 Aug 05; Vol. 7, pp. 150. Date of Electronic Publication: 2007 Aug 05.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
ErbB Receptors/*antagonists & inhibitors
Lung Diseases, Interstitial/*chemically induced
Lung Neoplasms/*drug therapy
Protein Kinase Inhibitors/*adverse effects
Quinazolines/*adverse effects
Antineoplastic Agents/adverse effects ; Carcinoma, Squamous Cell/drug therapy ; Cause of Death ; Erlotinib Hydrochloride ; Fatal Outcome ; Humans ; Lung Diseases, Interstitial/diagnostic imaging ; Male ; Middle Aged ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Tomography, X-Ray Computed
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies